4081. Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
作者: William J Muller.;Shabir A Madhi.;Beatriz Seoane Nuñez.;Manuel Baca Cots.;Miroslava Bosheva.;Ron Dagan.;Laura L Hammitt.;Conrado J Llapur.;Jose M Novoa.;Xavier Saez Llorens.;Amy Grenham.;Elizabeth J Kelly.;Vaishali S Mankad.;Manish Shroff.;Therese Takas.;Amanda Leach.;Tonya Villafana.; .
来源: N Engl J Med. 2023年388卷16期1533-1534页 4082. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
作者: Edward E Walsh.;Gonzalo Pérez Marc.;Agnieszka M Zareba.;Ann R Falsey.;Qin Jiang.;Michael Patton.;Fernando P Polack.;Conrado Llapur.;Pablo A Doreski.;Kumar Ilangovan.;Mika Rämet.;Yasushi Fukushima.;Nazreen Hussen.;Louis J Bont.;Jose Cardona.;Elliot DeHaan.;Giselle Castillo Villa.;Marinela Ingilizova.;Daniel Eiras.;Tarek Mikati.;Rupal N Shah.;Katherine Schneider.;David Cooper.;Kenneth Koury.;Maria-Maddalena Lino.;Annaliesa S Anderson.;Kathrin U Jansen.;Kena A Swanson.;Alejandra Gurtman.;William C Gruber.;Beate Schmoele-Thoma.; .
来源: N Engl J Med. 2023年388卷16期1465-1477页
Respiratory syncytial virus (RSV) infection causes considerable illness in older adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein-based (RSVpreF) vaccine in this population are unknown.
|